Your session is about to expire
← Back to Search
Behavioral Intervention
Collaborative Assessment and Management of Suicidality for Suicidal Thoughts (CAMS-4Kids Trial)
N/A
Recruiting
Led By Jeffrey A Bridge, PhD
Research Sponsored by Nationwide Children's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
current suicidal ideation and/or behavior
children between the ages of 5 - 11 years old, inclusive, at the time of consent
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, treatment completion (up to 12 weeks), 3 month and 6 month follow-up
Awards & highlights
CAMS-4Kids Trial Summary
This trial will help researchers understand if a new therapy called CAMS-4Kids is effective and accepted by children who are suicidal. The study will involve 10 young participants.
Who is the study for?
This trial is for children aged 5-11 with suicidal thoughts or behaviors, living with a caregiver who can consent to research. They must be clients of outpatient Behavioral Health Services and not currently in weekly therapy sessions with the Crisis Team.Check my eligibility
What is being tested?
CAMS-4Kids, an approach for managing suicidality in children, is being tested for its feasibility and acceptability. The study will involve enhancing treatment procedures and developing a manual based on feedback from participants.See study design
What are the potential side effects?
Since CAMS-4Kids is a psychological assessment and management approach rather than a medication, it does not have traditional side effects. However, discussing sensitive topics may cause discomfort or emotional distress.
CAMS-4Kids Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am currently experiencing thoughts or actions related to suicide.
Select...
My child is between 5 and 11 years old.
CAMS-4Kids Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, treatment completion (up to 12 weeks), 3 month and 6 month follow-up
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, treatment completion (up to 12 weeks), 3 month and 6 month follow-up
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
CAMS-4Kids Suicide Status Form-4 (SSF-4)
Change from baseline in psychosocial functioning and impairment on the Columbia Impairment Scale (CIS) at treatment completion (up to 12 weeks), 3 months and 6 months.
Change from baseline in suicidal ideation and behavior on the Columbia-Suicide Severity Rating Scale (C-SSRS) at treatment completion (up to 12 weeks) 3 months and 6 months
Secondary outcome measures
CAMS Rating Scale
Client Satisfaction Questionnaire (CSQ-8)
Therapeutic Alliance Scale for Caregivers and Parents (TASCP)
+1 moreCAMS-4Kids Trial Design
1Treatment groups
Experimental Treatment
Group I: CAMS-4KidsExperimental Treatment1 Intervention
Participants will receive up to 10 sessions of CAMS-4Kids
Find a Location
Who is running the clinical trial?
The Catholic University of AmericaOTHER
13 Previous Clinical Trials
2,529 Total Patients Enrolled
Nationwide Children's HospitalLead Sponsor
341 Previous Clinical Trials
5,220,496 Total Patients Enrolled
Jeffrey A Bridge, PhDPrincipal InvestigatorAbigail Wexner Research Institute at NCH
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My child is between 5 and 11 years old.I am currently experiencing thoughts or actions related to suicide.I have a mental health follow-up visit scheduled 4 weeks after my last assessment or crisis unit discharge.I understand the study procedures and do not have severe cognitive impairments.I am currently attending weekly therapy sessions with a crisis team.
Research Study Groups:
This trial has the following groups:- Group 1: CAMS-4Kids
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any available spots in this clinical research project?
"This trial, published on January 15th 2023 and last updated on September 27th 2022, is currently not accepting participants. Nevertheless, there are an abundance of other studies actively recruiting patients at this time - 219 in total."
Answered by AI
Does this trial cater to geriatric participants?
"This research study has stipulated a minimum age of 5 and an upper limit of 11 for eligibility."
Answered by AI
To which demographic is this clinical trial available?
"This clinical trial is admitting up to 10 individuals who have experienced parasuicide, aged between 5 and 11 years old."
Answered by AI
What is the overarching goal of this experiment?
"The primary endpoint of this study, assessed over a pre-treatment baseline and up to 12 weeks post-intervention, is the CAMS-4Kids Suicide Status Form-4 (SSF-4). Secondary outcomes include the Therapeutic Alliance Scale for Caregivers and Parents (TASCP), CAMS Rating Scale, and Client Satisfaction Questionnaire (CSQ-8)."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger